ANDA 89060, held by PLIVA. Benztropine Mesylate.
As of Nov 22, 2026, ANDA 89060 (Benztropine Mesylate), held by PLIVA, was first approved by FDA on Aug 10, 1988, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 10, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Benztropine Mesylate2MG · tablet;oral | Benztropine Mesylate | Rx |
| Dec 10, 2001 | Supplement 11Labeling | Approved | None posted |
| May 29, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Jul 7, 2000 | Supplement 9Manufacturing | Approved | None posted |
| Oct 27, 1998 | Supplement 8Labeling | Approved | None posted |
| Mar 9, 1998 | Supplement 4Labeling | Approved | None posted |
| Aug 13, 1997 | Supplement 6Manufacturing | Approved | None posted |
| Aug 13, 1997 | Supplement 7Manufacturing | Approved | None posted |
| May 11, 1994 | Supplement 5Manufacturing | Approved | None posted |
| Sep 24, 1992 | Supplement 2Manufacturing | Approved | None posted |
| Sep 24, 1992 | Supplement 3Bioequivalence | Approved | None posted |
| Feb 23, 1991 | Supplement 1Manufacturing | Approved | None posted |
| Aug 10, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters